Notice of Closed Meeting, 10079-10080 [2024-02874]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 30 / Tuesday, February 13, 2024 / Notices
the scope and severity of the breach
kept victims in the dark and delayed
them from taking protective actions,
making a bad situation even worse.
Today’s action builds on a series of
cases that have made clear that
maintaining a data retention and
deletion schedule is a critical part of
protecting consumers’ data security.2
The Commission has also made clear
that efforts to downplay the extent or
severity of a data breach run afoul of the
law.3
We are grateful to the Division of
Privacy and Identity Protection for their
excellent work, which enables us to
continue making key strides in
protecting people’s data. As businesses
face fresh incentives to hoard data to
train AI models,4 protecting Americans
from unlawful data practices will be
especially critical.
[FR Doc. 2024–02970 Filed 2–12–24; 8:45 am]
lotter on DSK11XQN23PROD with NOTICES1
BILLING CODE 6750–01–P
2 See, e.g., Press Release, Fed. Trade Comm’n,
Rite Aid Banned from Using AI Facial Recognition
After FTC Says Retailer Deployed Technology
Without Reasonable Safeguards (Dec. 19, 2023),
https://www.ftc.gov/news-events/news/pressreleases/2023/12/rite-aid-banned-using-ai-facialrecognition-after-ftc-says-retailer-deployedtechnology-without; Press Release, Fed. Trade
Comm’n, FTC Finalizes Order With Online Alcohol
Marketplace For Security Failures That Exposed
Personal Data of 2.5 Million People (Jan. 10, 2023),
https://www.ftc.gov/news-events/news/pressreleases/2023/01/ftc-finalizes-order-online-alcoholmarketplace-security-failures-exposed-personaldata-25-million; Press Release, Fed. Trade Comm’n,
FTC Brings Action Against Ed Tech Provider Chegg
for Careless Security that Exposed Personal Data of
Millions of Customers (Oct. 31, 2022); Press
Release, Fed. Trade Comm’n, FTC Takes Action
Against Global Tel*Link Corp. for Failing to
Adequately Secure Data, Notify Consumers After
Their Personal Data Was Breached (Nov. 16, 2023),
https://www.ftc.gov/news-events/news/pressreleases/2023/11/ftc-takes-action-against-globaltellink-corp-failing-adequately-secure-data-notifyconsumers-after. See also FTC Technology Blog,
Security Principles: Addressing Underlying Causes
of Risk in Complex Systems (Feb. 1, 2023), https://
www.ftc.gov/policy/advocacy-research/tech-at-ftc/
2023/02/security-principles-addressing-underlyingcauses-risk-complex-systems.
3 See, e.g., Press Release, Fed. Trade Comm’n,
FTC Takes Action Against CafePress for Data
Breach Cover Up (Mar. 15, 2022), https://
www.ftc.gov/news-events/news/press-releases/2022/
03/ftc-takes-action-against-cafepress-data-breachcover. See also FTC Technology Blog, Security
Beyond Prevention: The Importance of Effective
Breach Disclosures (May 20, 2022), https://
www.ftc.gov/policy/advocacy-research/tech-at-ftc/
2022/05/security-beyond-prevention-importanceeffective-breach-disclosures.
4 Press Release, Fed. Trade Comm’n, FTC and DOJ
Charge Amazon with Violating Children’s Privacy
Law by Keeping Kids’ Alexa Voice Recordings
Forever and Undermining Parents’ Deletion Request
(May 31, 2023), https://www.ftc.gov/news-events/
news/press-releases/2023/05/ftc-doj-chargeamazon-violating-childrens-privacy-law-keepingkids-alexa-voice-recordings-forever.
VerDate Sep<11>2014
16:57 Feb 12, 2024
Jkt 262001
GENERAL SERVICES
ADMINISTRATION
[Notice-PBS–2024–02; Docket No. 2024–
0002; Sequence No.3]
Notice of Availability of a Draft
Environmental Impact Statement for
the Alcan Land Port of Entry
Expansion and Modernization in Alcan,
Alaska; Withdrawal
Public Buildings Service,
General Services Administration (GSA).
ACTION: Notice; withdrawal.
AGENCY:
GSA is announcing the
withdrawal of the Notice of availability
of a draft environmental impact
statement for the Alcan land port of
entry expansion and modernization in
Alcan, Alaska. The February 7,2024
notice announced GSAs intent to
prepare a Draft Environmental Impact
Statement (DEIS) to analyze the
potential environmental effects of the
proposed expansion and modernization
of the existing Alcan LPOE.
FOR FURTHER INFORMATION CONTACT:
Aaron Evanson, Capital Project
Manager, (206) 445–5876, AlcanLPOE@
gsa.gov.
SUPPLEMENTARY INFORMATION: The
Notice of availability published in the
Federal Register on February 7, 2024.
GSA plans to publish at a later date.
SUMMARY:
10079
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
SIP24–012, Advancing Research in
Immunization Services Network (ARISe
Network).
Date: May 14, 2024.
Time: 10 a.m.–6 p.m., EDT.
Place: Teleconference/Web
Conference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Catherine Barrett, Ph.D., Scientific
Review Officer, National Center for
Chronic Disease Prevention and Health
Promotion, Centers for Disease Control
and Prevention, 4770 Buford Highway,
Mailstop S106–3, Atlanta, Georgia
30341–3717. Telephone: (404) 718–
7664; Email: CBarrett@cdc.gov.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Lois Mandell,
Director Regulatory Secretariat Division,
Office of Government-wide Policy.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–02847 Filed 2–12–24; 8:45 am]
[FR Doc. 2024–02885 Filed 2–12–24; 8:45 am]
BILLING CODE 6820–DL–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, CDC, pursuant to Public Law
92–463. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, CDC, pursuant to Public Law
92–463. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
E:\FR\FM\13FEN1.SGM
13FEN1
10080
Federal Register / Vol. 89, No. 30 / Tuesday, February 13, 2024 / Notices
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
GH21–001, Conducting Public Health
Research in Thailand: Technical
collaboration with the Ministry of
Public Health (MOPH) in the Kingdom
of Thailand; GH21–003, Advancing
Public Health Research in Kenya;
GH23–003, Conducting Public Health
Research with Universities in Thailand;
and GH24–033, Advancing Public
Health Research in Bangladesh.
Date: April 10, 2024.
Time: 9 a.m.–2 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Hylan Shoob, Ph.D., Scientific Review
Officer, Global Health Center, Centers
for Disease Control and Prevention,
1600 Clifton Road NE, Mailstop H21–9,
Atlanta, Georgia 30329–4027.
Telephone: (404) 639–4796; Email:
HShoob@cdc.gov.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–02874 Filed 2–12–24; 8:45 am]
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
lotter on DSK11XQN23PROD with NOTICES1
[FR Doc. 2024–02883 Filed 2–12–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, CDC, pursuant to Public Law
92–463. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
Jkt 262001
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
BILLING CODE 4163–18–P
Notice of Closed Meeting
16:57 Feb 12, 2024
92–463. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
SIP24–009, Arthritis Management and
Wellbeing Network (AMWN).
Date: May 15, 2024.
Time: 10 a.m.–6 p.m., EDT.
Place: Teleconference/Web
Conference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Natalie Brown, M.P.H., Scientific
Review Officer, National Center for
Chronic Disease Prevention and Health
Promotion, Centers for Disease Control
and Prevention, 4770 Buford Highway,
Mailstop S106–3, Atlanta, Georgia
30341–3717. Telephone: (404) 639–
4601; Email: NBrown3@cdc.gov.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
[FR Doc. 2024–02881 Filed 2–12–24; 8:45 am]
Centers for Disease Control and
Prevention
VerDate Sep<11>2014
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
SIP24–006, Nutrition Obesity Policy
Research and Evaluation Network
(NOPREN); SIP24–007, Physical
Activity Policy and Evaluation Research
Network (PAPREN): Policy
Implementation Research to Advance
Health Equity; and SIP24–010, Mental
Health and Chronic Disease Prevention
Network.
Date: May 2, 2024.
Time: 10 a.m.–6 p.m., EDT.
Place: Teleconference/Web
Conference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Catherine Barrett, Ph.D., Scientific
Review Officer, National Center for
Chronic Disease Prevention and Health
Promotion, Centers for Disease Control
and Prevention, 4770 Buford Highway,
Mailstop S106–3, Atlanta, Georgia
30341–3717. Telephone: (404) 718–
7664; Email: CBarrett@cdc.gov.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, CDC, pursuant to Public Law
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, CDC, pursuant to Public Law
92–463. The grant applications and the
discussions could disclose confidential
E:\FR\FM\13FEN1.SGM
13FEN1
]]>Agencies
[Federal Register Volume 89, Number 30 (Tuesday, February 13, 2024)]
[Notices]
[Pages 10079-10080]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02874]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is hereby given of the
following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended, and the Determination of the Director, Office of
Strategic Business Initiatives, Office of the Chief Operating Officer,
CDC, pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
[[Page 10080]]
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)--GH21-001, Conducting Public
Health Research in Thailand: Technical collaboration with the Ministry
of Public Health (MOPH) in the Kingdom of Thailand; GH21-003, Advancing
Public Health Research in Kenya; GH23-003, Conducting Public Health
Research with Universities in Thailand; and GH24-033, Advancing Public
Health Research in Bangladesh.
Date: April 10, 2024.
Time: 9 a.m.-2 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Hylan Shoob, Ph.D., Scientific
Review Officer, Global Health Center, Centers for Disease Control and
Prevention, 1600 Clifton Road NE, Mailstop H21-9, Atlanta, Georgia
30329-4027. Telephone: (404) 639-4796; Email: [email protected].
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-02874 Filed 2-12-24; 8:45 am]
BILLING CODE 4163-18-P
